Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Alice V Willrich

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Mayo Clinic Proceedings|December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple SclerosisRuba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
Clinical Chemistry and Laboratory Medicine|February 19, 2018
CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexesKari M Gurtner, Eslam Shosha, Sandra C Bryant, et al.
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixationMaria Alice V Willrich, Paula M Ladwig, Bruna D Andreguetto, et al.
Clinical Biochemistry|September 16, 2022
Characterizing M-protein light chain glycosylation via mass spectrometryIra D Miller, Mindy C Kohlhagen, Paula M Ladwig, et al.
Clinical Biochemistry|July 28, 2023
Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assaysBadr Al-Bawardy, Sarah M Jenkins, Melissa R Snyder, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2023
A universal reference interval for serum immunoglobulins free light chains may be outdatedSusan L Fink, Mark H Wener, Joseph W Rudolf, et al.
Digestive Diseases and Sciences|October 10, 2020
Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort StudyNienke Z Borren, Emma Paulides, Jody L Frinack, et al.
Blood Cancer Journal|September 2, 2022
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myelomaMaria Alice V Willrich, David L Murray, S Vincent Rajkumar, et al.
Clinical Biochemistry|November 16, 2023
Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassaysKornelia D Galior, Paula M Ladwig, Melissa R Snyder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statementHarald Hegen, Georgina Arrambide, Sharmilee Gnanapavan, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Mayo Clinic Proceedings|December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple SclerosisRuba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
Clinical Chemistry and Laboratory Medicine|February 19, 2018
CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexesKari M Gurtner, Eslam Shosha, Sandra C Bryant, et al.
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixationMaria Alice V Willrich, Paula M Ladwig, Bruna D Andreguetto, et al.
Clinical Biochemistry|September 16, 2022
Characterizing M-protein light chain glycosylation via mass spectrometryIra D Miller, Mindy C Kohlhagen, Paula M Ladwig, et al.
Clinical Biochemistry|July 28, 2023
Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assaysBadr Al-Bawardy, Sarah M Jenkins, Melissa R Snyder, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2023
A universal reference interval for serum immunoglobulins free light chains may be outdatedSusan L Fink, Mark H Wener, Joseph W Rudolf, et al.
Digestive Diseases and Sciences|October 10, 2020
Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort StudyNienke Z Borren, Emma Paulides, Jody L Frinack, et al.
Blood Cancer Journal|September 2, 2022
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myelomaMaria Alice V Willrich, David L Murray, S Vincent Rajkumar, et al.
Clinical Biochemistry|November 16, 2023
Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassaysKornelia D Galior, Paula M Ladwig, Melissa R Snyder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statementHarald Hegen, Georgina Arrambide, Sharmilee Gnanapavan, et al.
Pageof 5